Divis Laboratories Ltd | DIVI - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Alaunos Therapeutics USD 1.29M 865K 2026-03
Aurobindo Pharma INR 378.91B 28.57B 2026-03
Avita Medical AUD -16.65M 3.76M 2025-12
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Lupin INR 224.48B 28.16B 2026-03
Moderna USD 7.41B 1.24B 2026-03
Organon & Co USD 903M 151M 2026-03
Revvity USD 7.25B 125.54M 2025-12
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Tilray USD 1.58B 39.08M 2025-09
Viatris USD 14.66B 53.6M 2026-03
Xeris Pharmaceuticals USD 13.01M 678K 2026-03